Clinical trial
Multicenter Phase II Study Evaluating Docetaxel, CDDP, and Cetuximab as Induction Regimen Prior to Surgery in Chemo-naive Patients With NSCLC Stage IB, II and IIIA
NCT00406302 is registered in ClinicalTrials.gov with Wolfgang Hilbe as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter Phase II Study Evaluating Docetaxel, CDDP, and Cetuximab as Induction Regimen Prior to Surgery in Chemo-naive Patients With NSCLC Stage IB, II and IIIA
- Lead sponsor
- Wolfgang Hilbe
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 2007
- Completion date
- June 30, 2011
- Enrollment
- 41 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.